IGNT Stock Overview
Ingen Technologies, Inc. engages in the research and development of home healthcare products for the respiratory industry in United States.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Ingen Technologies, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.000001 |
52 Week High | US$0.0001 |
52 Week Low | US$0.000001 |
Beta | 0 |
1 Month Change | 0% |
3 Month Change | 0% |
1 Year Change | n/a |
3 Year Change | -99.86% |
5 Year Change | -99.86% |
Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
IGNT | US Medical Equipment | US Market | |
---|---|---|---|
7D | 0% | 1.4% | 1.2% |
1Y | n/a | -0.7% | 24.7% |
Return vs Industry: Insufficient data to determine how IGNT performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how IGNT performed against the US Market.
Price Volatility
IGNT volatility | |
---|---|
IGNT Average Weekly Movement | n/a |
Medical Equipment Industry Average Movement | 7.3% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: IGNT's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine IGNT's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1999 | n/a | Dave Hanson | www.ingen-tech.com |
Ingen Technologies, Inc. engages in the research and development of home healthcare products for the respiratory industry in United States. It offers oxygen flow meters and nasal cannulas under the Oxyview and Smart Nasal Cannula trademark names for patients suffering with chronic obstructive pulmonary disease. The company was founded in 1999 and is based in Riverside, California.
Ingen Technologies, Inc. Fundamentals Summary
IGNT fundamental statistics | |
---|---|
Market cap | n/a |
Earnings (TTM) | -US$668.58k |
Revenue (TTM) | US$13.57k |
0.0x
P/S Ratio0.0x
P/E RatioIs IGNT overvalued?
See Fair Value and valuation analysisEarnings & Revenue
IGNT income statement (TTM) | |
---|---|
Revenue | US$13.57k |
Cost of Revenue | US$583.00 |
Gross Profit | US$12.98k |
Other Expenses | US$681.57k |
Earnings | -US$668.58k |
Last Reported Earnings
May 31, 2015
Next Earnings Date
n/a
Earnings per share (EPS) | 0 |
Gross Margin | 0.00% |
Net Profit Margin | 0.00% |
Debt/Equity Ratio | 0.0% |
How did IGNT perform over the long term?
See historical performance and comparison